
Saturday, May 25, 2024 11:51:50 AM
I missed something that no one has talked about from the companies presentation, Cancer treatment as new product for revenue. How can Si3n4 be used for cancer treatment? Is it filtering membrane to capture tumor cells? Is that the new market and product opportunity?
Ultrathin silicon nitride membrane with slit-shaped pores for high-performance separation of circulating tumor cells
The silicon nitride (Si3N4) filtering membrane was fabricated via the standard microfabrication technology, which can be easily scaled up to mass-production. 6 µm was determined as the optimum width of the filtering pores to better separate CTCs in whole blood, which can reach a high capture efficiency of ~96%.
https://pubmed.ncbi.nlm.nih.gov/35997043/
List of industries and potential products that they could and are developing products for. The sectors where i know they have products in development ive broken down further. Silicon Nitride could be in most healthcare related products with all its uses.
Armor (Body, vehicle, aerospace)
Energy (Accident tolerant fuel containment systems for nuclear reactors. Receiver tubes for concentrated solar-thermal power systems.)
Aviation and Aerospace Industry (combustor, radomes, and RF windows, engine ignighters, turbine blades, heat exchangers.) (Outside of Silicon Nitride are CMC for airplane engine components)
Hypersonic Industry (CMCs for hypersonics as well)
Electronics Industry (Biosensors & optics)
The Ideal Biomaterial (Spinal, Dental, Craniomaxillofacial, Foot Osteotomy & Fusion, Wound Care, Arthroplasty (Hip, Knee, Shouler, Ankle))
Antipathogenic (Masks, Medical Tubing, Surgical Gowns, Drapes, and Curtains, Filters, Consumer Products (High Touch Products), Public Transportation (High Touch Surfaces))
Biosensors
Rapid Prototyping
RF COMPONENTS
Welding
Automotive
Thats just the applications mentioned on their website, presentations, & SEC filings that i noticed. A few more are listed within the following scientific study:
Silicon Nitride, a Close to Ideal Ceramic Material for Medical Application
examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.
https://www.mdpi.com/2571-6131/4/2/16/htm
They have some big names behind the scenes like Morgan Ceramics & Zimmer Biomet. Im guessing Solventum as well.
========================================
Update on Sintx current market cap and float before Tuesdays RS.
Market Cap: $9,588,789
Shares Float: 141,846,000
Post RS float = 709,230
https://stocktwits.com/HaltTradeAlert/message/574273137
Could it be that there is a strategy to distract people away from looking at the basic data?
Is all this an exercise to create more and more forum verbiage to drown out any serious discussion of evidence?
Recent SINT News
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 03/19/2025 09:15:41 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/19/2025 12:00:35 PM
- SINTX Technologies Announces Publication of Study Confirming Superior Performance of Silicon Nitride in Cervical Spine Fusion • GlobeNewswire Inc. • 03/19/2025 12:00:00 PM
- Sintx Technologies Announces Board Chairman Transition • GlobeNewswire Inc. • 03/17/2025 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/13/2025 08:15:11 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/27/2025 03:46:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/26/2025 01:30:29 PM
- SINTX Technologies Announces $5 Million Private Placement Priced At-the-Market under Nasdaq Rules • GlobeNewswire Inc. • 02/26/2025 01:00:00 PM
- SINTX Technologies Sells Technology Assesment and Transfer Subsidiary to Focus on Medical Device Market • GlobeNewswire Inc. • 02/20/2025 11:15:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/20/2025 11:10:05 AM
- This Healthcare Stock Rose Sharply On USPTO Issuance • AllPennyStocks.com • 02/19/2025 07:10:00 PM
- SINTX Receives Issuance of U.S. Patent for Silicon Nitride-Functionalized Zirconia-Toughened Alumina Ceramic Biomaterial • GlobeNewswire Inc. • 02/19/2025 11:00:00 AM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 02/14/2025 10:08:19 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 02/14/2025 09:42:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/23/2024 09:15:30 PM
- SINTX Technologies Secures Patent Allowance for Wide-Ranging Silicon Nitride Biomaterial Applications • GlobeNewswire Inc. • 12/17/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/13/2024 09:15:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/29/2024 06:15:19 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 11/26/2024 11:10:12 AM
- SINTX Technologies and NED Medical Partner to Advance Cutting-Edge Ceramic Microsphere Medical Devices for Cancer Treatment • GlobeNewswire Inc. • 11/21/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/19/2024 10:13:22 PM
- SINTX Technologies Appoints Gregg R. Honigblum as Chief Strategy Officer • GlobeNewswire Inc. • 11/19/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/18/2024 11:15:16 AM
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 11/15/2024 12:25:52 AM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/14/2024 09:15:08 PM
FEATURED LaFleur Minerals Provides Update on Beacon Mill Restart, Results of Annual General and Special Meeting, and Swanson Gold Deposit Exploration and Drilling Updates • Mar 21, 2025 9:40 AM
Basanite Industries, Inc. Appoints Michael D. Nelson as Chief Executive Officer • BASA • Mar 21, 2025 9:01 AM
Fifty 1 Labs, Inc. (FITY) Acquires Genetic Networks, Working to Secure Multi-Million Dollar DoD Contracts, and Positions for Rapid Expansion in Biotech Innovation • FITY • Mar 20, 2025 9:00 AM
VAYK Forms Partnership with Airbnb Investing Group to Offer Service Solution • VAYK • Mar 20, 2025 9:00 AM
4Cable TV International, Inc. (CATV) Facilitates Acquisition of Genetic Networks LLC by Fifty 1 Labs, Inc. (FITY), Announces Dividend for CATV Shareholders, and Sets Stage for Transformative Reverse Merger • CATV • Mar 20, 2025 8:30 AM
NUBURU Announces Elimination of 100% of its Long-Term Indebtedness and $5.15 Million Strategic Investment in Supply@ME Capital • BURU • Mar 19, 2025 8:53 AM